Allworth Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Allworth Financial’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$971	–	5126
2025 Q3	$971	Hold	25	–	–	﹤0.01%	4260
2025 Q2	$843	Hold	25	–	–	﹤0.01%	4004
2025 Q1	$819	Hold	25	–	–	﹤0.01%	3534
2024 Q4	$1.02K	Hold	25	–	–	﹤0.01%	3387
2024 Q3	$1.13K	Hold	25	–	–	﹤0.01%	3178
2024 Q2	$1.12K	Hold	25	–	–	﹤0.01%	3130
2024 Q1	$1.14K	Hold	25	–	–	﹤0.01%	3040
2023 Q4	$1.16K	Hold	25	–	–	﹤0.01%	2905
2023 Q3	$1.02K	Hold	25	–	–	﹤0.01%	2842
2023 Q2	$1.21K	Hold	25	–	–	﹤0.01%	2667
2023 Q1	$1.23K	Buy	+25	New	+$1.29K	﹤0.01%	2596

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Allworth Financial's GNOM Position: Q4 2025 in Review

Allworth Financial sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 25 shares — an estimated $971 sold.

Allworth Financial first reported a position in GNOM in Q1 2023 and held it in 11 quarters. The position peaked at $1.23K in Q1 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

Allworth Financial reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Allworth Financial sold 25 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $971.
Allworth Financial first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 11 quarters.
Allworth Financial's Global X Genomics & Biotechnology ETF position peaked at $1.23K in Q1 2023.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.